In summary, the present meta-analysis found novel evidence that the RNASEL Arg462Gln polymorphism is associated with increased prostate cancer risk in Africans; moreover, the RNASEL Asp541Glu polymorphism is associated with prostate cancer risk in Europeans and Africans, confirming the results of previous meta-analyses. Here, RNASEL is linked to prostate carcinoma.